Published in Volume
82, Issue 4 (October 1988)
J Clin Invest. 1988;82(4):1471–1476.
doi:10.1172/JCI113754.
Copyright ©
1988, The American Society for
Clinical Investigation.
Research Article
Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion.
J Schwaber, N Koenig and J Girard
Children's Hospital, Boston, Massachusetts 02115.
Published October 1988
The X chromosome-linked antibody deficiency disease, X-linked agammaglobulinemia (XLA), results from failure of B lymphoid development. In the minor form of XLA, B lymphoid development terminates at the stage of immature B lymphocytes that produce truncated Ig heavy (H) chains composed of D-J-C(mu/delta), resulting from failure of VH gene rearrangement. Fusion of B cells from a patient with the minor form of XLA with mouse myeloma results in complementation of this defect; hybrid cells produce full-length H chains composed of VH-D-JH-C. The VH gene is of human origin. Complementation occurs independent of retention or loss of the human X (XLA) chromosome in the hybrid cells. These results indicate that the D-JH-C structure of the XLA B cells is fully functional for the subsequent rearrangement of a VH gene element, and that failure of immunoglobulin expression is susceptible to correction.
Browse pages
Click on an image below to see the page. View
PDF of the complete article